Published in Am J Ophthalmol on April 01, 2010
Ocular Response Analyzer. J Curr Glaucoma Pract (2012) 0.75
HLA class I/II matching and chronic endothelial cell loss in penetrating normal risk keratoplasty. Acta Ophthalmol Scand (2004) 1.56
Toxic vitreitis outbreak after intravitreal injection. Retina (2010) 1.51
Successful treatment of cystoid macular edema with valdecoxib. J Cataract Refract Surg (2007) 1.50
The medical and surgical treatment of glaucoma. Dtsch Arztebl Int (2009) 1.44
Trabectome surgery for primary and secondary open angle glaucomas. Graefes Arch Clin Exp Ophthalmol (2013) 1.33
Descemet stripping endothelial keratoplasty--rapid recovery of visual acuity. Dtsch Arztebl Int (2013) 1.24
Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency. Ophthalmology (2004) 1.23
Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Cornea (2012) 1.10
Long-term keratoplasty graft survival. Ophthalmology (2013) 1.09
Influencing factors on chronic endothelial cell loss characterised in a homogeneous group of patients. Br J Ophthalmol (2002) 1.08
Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study. Transplantation (2005) 1.07
Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients. Acta Ophthalmol (2008) 1.07
[Chronic endothelial cell loss of the graft after penetrating keratoplasty: influence of endothelial cell migration from graft to host]. Klin Monbl Augenheilkd (2002) 1.04
Influence of donor characteristics on descemet membrane endothelial keratoplasty. Cornea (2014) 1.03
Long-term graft survival in penetrating keratoplasty: the biexponential model of chronic endothelial cell loss revisited. Cornea (2010) 1.03
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology (2002) 1.02
Clinical results of 123 femtosecond laser-assisted penetrating keratoplasties. Graefes Arch Clin Exp Ophthalmol (2012) 1.01
Corneal surface reconstruction using adult mesenchymal stem cells in experimental limbal stem cell deficiency in rabbits. Acta Ophthalmol (2009) 0.99
Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study. Graefes Arch Clin Exp Ophthalmol (2003) 0.98
Endothelial cell loss after autologous rotational keratoplasty. Graefes Arch Clin Exp Ophthalmol (2004) 0.98
[Systematic EDP-supported acquisition of follow-up data of keratoplasty patients--report on ten years' experience]. Klin Monbl Augenheilkd (2003) 0.95
Morphological and immunohistochemical changes after corneal cross-linking. Cornea (2013) 0.95
Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty. Transplantation (2004) 0.93
Penetrating limbo-keratoplasty for granular and lattice corneal dystrophy: survival of donor limbal stem cells and intermediate-term clinical results. Ophthalmology (2004) 0.93
A new surgical triple procedure in pseudoexfoliation glaucoma using cataract surgery, Trabectome, and trabecular aspiration. Graefes Arch Clin Exp Ophthalmol (2014) 0.93
Matching of the minor histocompatibility antigen HLA-A1/H-Y may improve prognosis in corneal transplantation. Transplantation (2006) 0.92
Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma. Graefes Arch Clin Exp Ophthalmol (2005) 0.92
Active transforming growth factor-beta2 is increased in the aqueous humor of keratoconus patients. Mol Vis (2007) 0.91
Accelerated corneal graft rejection in baby rats. Br J Ophthalmol (2009) 0.91
Soluble Fas ligand and transforming growth factor beta2 in the aqueous humor of patients with endothelial immune reactions after penetrating keratoplasty. Arch Ophthalmol (2002) 0.91
Toxic anterior segment syndrome following penetrating keratoplasty. Arch Ophthalmol (2008) 0.90
Allogenic limbo-keratoplasty with conjunctivoplasty, mitomycin C, and amniotic membrane for bilateral limbal stem cell deficiency. Ophthalmology (2012) 0.88
The impact of corneal edema on intraocular pressure measurements using goldmann applanation tonometry, Tono-Pen XL, iCare, and ORA: an in vitro model. J Glaucoma (2013) 0.88
An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty. Transplantation (2006) 0.87
Retrospective analysis of the success and safety of Gold Micro Shunt Implantation in glaucoma. BMC Ophthalmol (2013) 0.87
Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Ophthalmology (2012) 0.87
Pilot study of a new posterior chamber phakic intraocular lens (epi.lens) for high myopia. J Refract Surg (2011) 0.86
Distinct cytokine pattern in aqueous humor during immune reactions following penetrating keratoplasty. Mol Vis (2010) 0.86
Correlation between visual acuity and interface reflectivity measured by pentacam following DSAEK. Acta Ophthalmol (2013) 0.85
Expression of p16 in conjunctival intraepithelial neoplasia does not correlate with HPV-infection. Open Ophthalmol J (2008) 0.85
Differential contribution of natural killer cells to corneal graft rejection in 3-week-old versus mature rats. Transplantation (2003) 0.85
The intrastromal corneal ring in penetrating keratoplasty-long-term results of a prospective randomized study. Cornea (2011) 0.84
Cell-by-cell alignment of repeated specular microscopy images from the same eye. PLoS One (2013) 0.84
Comparative measurement of intraocular pressure by Icare tonometry and Airpuff tonometry in healthy subjects and patients wearing therapeutic soft contact lenses. Graefes Arch Clin Exp Ophthalmol (2013) 0.84
Determination of active TGF-beta2 in aqueous humor prior to and following cryopreservation. Mol Vis (2006) 0.84
HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty. Dev Ophthalmol (2003) 0.84
Morphological comparison of specular microscopy images may be a more robust indicator for endothelial stability than cell density estimations. Cornea (2013) 0.82
Simulation and prediction of cardiotherapeutical phenomena from a pulsatile model coupled to the Guyton circulatory model. IEEE Trans Biomed Eng (2002) 0.82
Predicting the risk for corneal graft rejection by aqueous humor analysis. Mol Vis (2011) 0.82
Clinicopathological findings in persistent corneal cowpox infection. JAMA Ophthalmol (2013) 0.82
Improved wound stability of top-hat profiled femtosecond laser-assisted penetrating keratoplasty in vitro. Cornea (2012) 0.82
Visual Outcomes After Cataract Surgery: Multifocal Versus Monofocal Intraocular Lenses. J Refract Surg (2015) 0.82
Concise reviews: the role of biomechanics in the limbal stem cell niche: new insights for our understanding of this structure. Stem Cells (2015) 0.81
Conjunctival epithelial cells with donor-derived genome after human haematopoietic stem-cell transplantation. Transplantation (2009) 0.81
Conjunctival HLA-DR and CD8 expression detected by impression cytology in ocular graft versus host disease. Mol Vis (2013) 0.81
Host-derived endothelial regeneration of corneal transplants in a rat keratoplasty model. Ophthalmic Res (2014) 0.80
Synergism of RAD and cyclosporin A in prevention of acute rat corneal allograft rejection. Cornea (2002) 0.80
NK cell depletion delays corneal allograft rejection in baby rats. Mol Vis (2010) 0.80
Epithelial marker expression in Salzmann nodular degeneration shows characteristics of limbal transient amplifying cells and alludes to an involvement of the epithelium in its pathogenesis. Acta Ophthalmol (2010) 0.80
A corneal dystrophy associated with transforming growth factor beta-induced Gly623Asp mutation an amyloidogenic phenotype. Ophthalmology (2008) 0.79
Histological and immunohistochemical characterisation of conjunctival graft vs host disease following haematopoietic stem cell transplantation. Graefes Arch Clin Exp Ophthalmol (2006) 0.79
Operational post-keratopasty graft tolerance due to differential HLAMatchmaker matching. Mol Vis (2010) 0.78
Contrast sensitivity with bifocal intraocular lenses is halved, as measured with the Freiburg Vision Test (FrACT), yet patients are happy. Graefes Arch Clin Exp Ophthalmol (2014) 0.77
Quantification of retrograde axonal transport in the rat optic nerve by fluorogold spectrometry. PLoS One (2012) 0.77
Intra- and postoperative risks and complications of small-gauge (23-G) versus conventional (20-G) vitrectomy for macular surgery. Eur J Ophthalmol (2014) 0.77
Is there an endothelial cell toxicity of light-adjustable lens UVA irradiation on the human corneal endothelium? Eur J Ophthalmol (2012) 0.77
Ab Interno Trabeculectomy With the Trabectome as a Valuable Therapeutic Option for Failed Filtering Blebs. J Glaucoma (2016) 0.77
Topical pimecrolimus does not prolong clear graft survival in a rat keratoplasty model. Graefes Arch Clin Exp Ophthalmol (2007) 0.77
Inhibition of corneal inflammation following keratoplasty by birch leaf extract. Exp Eye Res (2012) 0.77
Light scattering and wavefront aberrations in in vivo imaging of the rat eye: a comparison study. Invest Ophthalmol Vis Sci (2011) 0.77
Long term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty. Cornea (2009) 0.77
Cyclooxygenase-2 inhibitors: a new therapeutic option in the treatment of macular edema after cataract surgery. J Cataract Refract Surg (2005) 0.77
Corneal endothelial loss after crosslinking with riboflavin and ultraviolet-A. Graefes Arch Clin Exp Ophthalmol (2012) 0.76